The causal role of XO in the pathophysiology of vascular damage is substantiated by the observation that inhibition of harmfully increased XO activity leads to improvement across a range of surrogate markers in patients with cardiovascular and renal disorders [18–20]. The gene discussed is XDH; the disease is kidney disorder.